共 24 条
[5]
Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer?: Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2005, 23 (25)
:6139-6148